Log in to save to my catalogue

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and p...

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_884988997

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated [beta]-cell death

About this item

Full title

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated [beta]-cell death

Publisher

New York: American Diabetes Association

Journal title

Diabetes (New York, N.Y.), 2011-08, Vol.60 (8), p.2112

Language

English

Formats

Publication information

Publisher

New York: American Diabetes Association

More information

Scope and Contents

Contents

OBJECTIVE--CD4 T-cells secreting interleukin (IL)-17 are implicated in several human autoimmune diseases, but their role in type 1 diabetes has not been defined. To address the relevance of such cells, we examined IL-17 secretion in response to [beta]-cell autoantigens, IL-17A gene expression in islets, and the potential functional consequences of...

Alternative Titles

Full title

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated [beta]-cell death

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_884988997

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_884988997

Other Identifiers

ISSN

0012-1797

E-ISSN

1939-327X

DOI

10.2337/db10-1643

How to access this item